Multifactorial Strategies for the Prevention of the Risks of Ulceration in Patients Affected by Diabetic Foot (DARE-DiaFoot)
Multifactorial Strategies for the Prevention of the Risks of Ulceration in Patients Affected by Diabetic Foot
Istituto Ortopedico Rizzoli
150 participants
Nov 3, 2025
INTERVENTIONAL
Conditions
Summary
This is a no-profit, multicentre, national, clinical trial for the prevention of the complications of the diabetic foot in two populations of patients with diabetes mellitus type-2.
Eligibility
Inclusion Criteria4
- Male and female patients aged between 18 and 75 years.
- Diabetes mellitus type-2 patients with mild to moderate risk of ulceration at the foot (grade 2).
- Male and female patients aged between 18 and 75 years.
- Patients with diabetes mellitus type-2 and diabetic foot with an history of ulcerative lesions (grade 3), healed for at least 6 months.
Exclusion Criteria9
- History or evidence of ulcers at the foot
- Infections in progress, ongoing neoplasms
- Immunosuppressive therapies, and cortisone-based therapy
- Pregnancy and lactation
- Inability to provide informed consent
- Infections in progress, ongoing neoplasms
- Immunosuppressive therapies, and cortisone-based therapy
- Pregnancy and lactation
- Inability to provide informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Population 1 receives all three groups of analyses:Clinical-metabolical analyses, Biological-biochemical analyses, and Biomechanical-functional analyses.
Population 2 receives two groups of analyses:Clinical-metabolical analyses and Biological-biochemical analyses.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07021222